Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Comparison of pneumatic displacement for submacular hemorrhages with gas alone and gas plus tissue plasminogen activator.

Fujikawa M, Sawada O, Miyake T, Kakinoki M, Sawada T, Kawamura H, Sakaguchi H, Gomi F, Ohji M.

Retina. 2013 Oct;33(9):1908-14. doi: 10.1097/IAE.0b013e318287d99d.

PMID:
23594720
2.

Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.

Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC.

Am J Ophthalmol. 2014 Jun;157(6):1250-7. doi: 10.1016/j.ajo.2014.02.007. Epub 2014 Feb 13.

PMID:
24531021
3.

Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.

Chen CY, Hooper C, Chiu D, Chamberlain M, Karia N, Heriot WJ.

Retina. 2007 Mar;27(3):321-8.

PMID:
17460587
4.

Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.

Mizutani T, Yasukawa T, Ito Y, Takase A, Hirano Y, Yoshida M, Ogura Y.

Graefes Arch Clin Exp Ophthalmol. 2011 Aug;249(8):1153-7. doi: 10.1007/s00417-011-1649-1. Epub 2011 Mar 29.

PMID:
21445629
5.

Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.

Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, Blodi BA, Elner SG.

Ophthalmology. 1999 Oct;106(10):1900-6; discussion 1906-7.

PMID:
10519583
6.

Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.

Treumer F, Roider J, Hillenkamp J.

Br J Ophthalmol. 2012 May;96(5):708-13. doi: 10.1136/bjophthalmol-2011-300655. Epub 2011 Dec 15.

PMID:
22174095
7.

Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.

Kung YH, Wu TT, Hong MC, Sheu SJ.

J Ocul Pharmacol Ther. 2010 Oct;26(5):469-74. doi: 10.1089/jop.2010.0066.

PMID:
20925578
8.

Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.

Papavasileiou E, Steel DH, Liazos E, McHugh D, Jackson TL.

Retina. 2013 Apr;33(4):846-53. doi: 10.1097/IAE.0b013e318271f278.

PMID:
23400079
9.

Vitreous hemorrhage complicating intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.

Wu TT, Kung YH, Hong MC.

Retina. 2011 Nov;31(10):2071-7. doi: 10.1097/IAE.0b013e31822528c8.

PMID:
21817964
10.

Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator.

Cakir M, CekiƧ O, Yilmaz OF.

Eur J Ophthalmol. 2010 May-Jun;20(3):565-71.

PMID:
20037915
11.

Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.

Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS.

Arch Ophthalmol. 2001 Jan;119(1):28-32.

PMID:
11146723
12.

INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.

de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, van Meurs JC.

Retina. 2016 May;36(5):914-25. doi: 10.1097/IAE.0000000000000954.

PMID:
26807631
13.

Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.

Fang IM, Lin YC, Yang CH, Yang CM, Chen MS.

Eye (Lond). 2009 Feb;23(2):397-406. Epub 2007 Nov 2.

PMID:
17975562
14.

Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.

Mayer WJ, Hakim I, Haritoglou C, Gandorfer A, Ulbig M, Kampik A, Wolf A.

Acta Ophthalmol. 2013 May;91(3):274-8. doi: 10.1111/j.1755-3768.2011.02264.x. Epub 2011 Sep 22.

15.
16.

Pneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activator.

Yang PM, Kuo HK, Kao ML, Chen YJ, Tsai HH.

Chang Gung Med J. 2005 Dec;28(12):852-9.

17.

Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.

Haupert CL, McCuen BW 2nd, Jaffe GJ, Steuer ER, Cox TA, Toth CA, Fekrat S, Postel EA.

Am J Ophthalmol. 2001 Feb;131(2):208-15.

PMID:
11228297
18.

Supplemental Content

Support Center